The Wiskott-Aldrich syndrome (WAS) is an X-linked (Xp11.22) recessive immunodeficiency syndrome characterized by susceptibility to opportunistic and pyogenic infections, thrombocytopenia, and eczema. Previous studies of obligate carriers of WAS documented that nonrandom inactivation of the X chromosome carrying the defective gene is observed in all peripheral blood cells. The existence of both abnormal platelets and lymphocytes is consistent with a defect that affects early hematopoietic precursors. We isolated CD34+ hematopoietic progenitor cells collected from obligate carriers of WAS by apheresis and used polymerase chain reaction analysis of a polymorphic variable number of repeats (VNTR) within the X-linked androgen receptor to document nonrandom inactivation. These data show that nonrandom inactivation of the X-chromosome in WAS-obligate carriers occurs early during hematopoietic differentiation.
ARTICLES|
May 1, 1995
Nonrandom inactivation of the X chromosome in early lineage hematopoietic cells in carriers of Wiskott-Aldrich syndrome
G Wengler,
G Wengler
Center for Blood Research, Children's Hospital, Boston, MA, USA.
Search for other works by this author on:
JB Gorlin,
JB Gorlin
Center for Blood Research, Children's Hospital, Boston, MA, USA.
Search for other works by this author on:
JM Williamson,
JM Williamson
Center for Blood Research, Children's Hospital, Boston, MA, USA.
Search for other works by this author on:
FS Rosen,
FS Rosen
Center for Blood Research, Children's Hospital, Boston, MA, USA.
Search for other works by this author on:
DH Bing
DH Bing
Center for Blood Research, Children's Hospital, Boston, MA, USA.
Search for other works by this author on:
Blood (1995) 85 (9): 2471–2477.
Citation
G Wengler, JB Gorlin, JM Williamson, FS Rosen, DH Bing; Nonrandom inactivation of the X chromosome in early lineage hematopoietic cells in carriers of Wiskott-Aldrich syndrome. Blood 1995; 85 (9): 2471–2477. doi: https://doi.org/10.1182/blood.V85.9.2471.bloodjournal8592471
Download citation file: